chartexchange

ZNTL
Zentalis Pharmaceuticals, Inc. Common Stock
stockNASDAQ

At CloseOct 2, 2026 3:59:52 PM EDT
2.50USD-4.031%(-0.11)1,451,185
After-hoursOct 2, 2026 4:54:30 PM EDT
2.5197USD+0.788%(+0.0197)
Loading…
Loading…
238.10M
Healthcare
Biotechnology
HQ
New York, NY, USA
Previous Close
$2.61
Beta
1.94
52-Week High
$6.95 2026-04-10
52-Week Low
$1.21 2025-11-07
SMA 50
$3.75
SMA 200
$3.42
Avg. Vol 10D
1.57M
Avg. Vol 30D
1.11M
Avg. Vol 90D
1.19M
Relative Vol
1.31
48.56M
0.4900%
1,300,000
1,398
Nov 9, 2026 (35d)
ZNTL Profile

developing potentially best-in-class, novel small molecules targeting fundamental biological pathways in cancer

ZNTL Performance
PeriodPriceDateChangeBeta
1W2.602026-09-28-3.27%-7.418
1M3.992026-09-04-36.97%0.792
3M4.722026-07-06-46.72%0.722
6M2.692026-04-06-6.51%1.172
1Y1.612025-10-03+56.21%1.942
2Y3.372024-10-04-25.37%—
5Y66.922021-10-04-96.24%1.710
ZNTL Stock Summary

Zentalis Pharmaceuticals, Inc. Common Stock (NASDAQ:ZNTL) stock price today is $2.52, and today's volume is 1,451,185. ZNTL is down 3.455% today. The 30 day average volume is 1.11M. ZNTL market cap is $238.10M with 94.67M shares outstanding.